Printer Friendly

Researchers set up new organ-on-a-chip technology to study blood vessel formation.

M2 EQUITYBITES-February 2, 2018-Researchers set up new organ-on-a-chip technology to study blood vessel formation


A team of researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM have established a new organ-on-a-chip technology to study blood vessel formation and the drugs targeting this mechanism, it was reported yesterday.

The technology is intended to help in repairing a human blood vessel and in the development of new capillaries from a single vessel in response to proper biochemical indicating cues. New organ-on-a-chip technology will also be utilised to develop drugs targeting this growth to treat cancer and blood-vessel-related diseases.

The IIS lecturer, Yukiko Matsunaga, has been working in the SMMIL-E project, which is a joint French-Japanese project against cancer. The project is supported by the CNRS, COL, Universite de Lille and the University of Tokyo. They are utilising tissue engineering and organ-on-a-chip technology to study different biological phenomena, including angiogenesis.

((Comments on this story may be sent to

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Feb 2, 2018
Previous Article:Automation Anywhere elects Clyde Hosein as CFO.
Next Article:Sage Therapeutics achieves positive results in phase 1/2 trial of SAGE-217.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters